FDA Approval Advances Basal Insulin - Poll - MDSpire

FDA Approval Advances Basal Insulin

Weekly dosing reduces injection frequency vs daily regimens, with phase 3 data supporting efficacy and class-consistent safety.

  • By

  • Kathryn Wighton

  • March 27, 2026

  • 2 min

Share

Original Source(s)

FDA Approval Advances Basal Insulin

  • by Kathryn Wighton

  • March 27, 2026

Related Content

Effects of altitude and sociodemographic factors on cardiometabolic disorders in the southwestern plateau areas of China

Mapping the gut microbiota-diabetic peripheral neuropathy research landscape: a bibliometric analysis of emerging trends and translational frontiers

Predictors of early response to GnRH and gonadotropin therapy in pediatric patients with suspected dual congenital hypogonadotropic hypogonadism: a retrospective single-center study